This inventor holds 1 USPTO granted patent. Top assignee: Morishita Pharmaceutical Co., Ltd.. Active years: 1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1980
Title: The Innovative Mind of Tomokazu Yuizono
Introduction
Tomokazu Yuizono, an accomplished inventor based in Kyoto, Japan, is known for his groundbreaking contributions to pharmaceutical chemistry. With a focus on developing novel compounds, Yuizono has made significant strides in the field of medicinal chemistry, particularly with his research into thioamide derivatives.
Latest Patents
Yuizono holds a patent for "Novel thioamide derivatives containing a pyridazine group," which presents unique pyridazine-containing thioamide derivatives. The structural formula includes variations wherein R1 represents hydrogen, methyl, phenyl, or mercapto, while R2, R3, and R4 can be hydrogen or methyl. These derivatives have demonstrated exceptional gastric antisecretory activity, highlighting their potential therapeutic applications.
Career Highlights
Yuizono is currently employed at Morishita Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His innovative approach and dedication to research have not only advanced his career but have also propelled the company's research initiatives forward.
Collaborations
Throughout his professional journey, Tomokazu Yuizono has collaborated with notable coworkers, including Masahiro Takaya and Toshihiro Yamada. Their teamwork is indicative of a collaborative environment that fosters innovation and enhances the development of new therapeutic agents.
Conclusion
Tomokazu Yuizono's contributions to pharmaceutical chemistry through his invention of novel thioamide derivatives underscore the importance of innovation in healthcare. His work not only exemplifies individual brilliance but also illustrates the power of collaboration within a dynamic company like Morishita Pharmaceutical Co., Ltd. As he continues to pursue further research, the impact of his patents may pave the way for new advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile